Citations (79)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Olayide A Arodola & Mahmoud ES Soliman. (2017) Quantum mechanics implementation in drug-design workflows: does it really help?. Drug Design, Development and Therapy 11, pages 2551-2564.
Read now
Read now
. (2012) Luck of the draw? Serendipity, accident, chance and misfortune in organization and design. Culture and Organization 18:5, pages 433-436.
Read now
Read now
Amy C Shurtleff, Tam L Nguyen, David A Kingery & Sina Bavari. (2012) Therapeutics for filovirus infection: traditional approaches and progress towards in silico drug design. Expert Opinion on Drug Discovery 7:10, pages 935-954.
Read now
Read now
Peter Buchwald. (2007) Computer-aided retrometabolic drug design: soft drugs. Expert Opinion on Drug Discovery 2:7, pages 923-933.
Read now
Read now
T.I. Oprea. (2001) Rapid Estimation of Hydrophobicity for Virtual Combinatorial Library Analysis. SAR and QSAR in Environmental Research 12:1-2, pages 129-141.
Read now
Read now
Articles from other publishers (74)
Piermichele Kobauri, Frank J. Dekker, Wiktor Szymanski & Ben L. Feringa. (2023) Rational Design in Photopharmacology with Molecular Photoswitches. Angewandte Chemie International Edition 62:30.
Crossref
Crossref
Piermichele Kobauri, Frank J. Dekker, Wiktor Szymanski & Ben L. Feringa. (2023) Rational Design in Photopharmacology with Molecular Photoswitches. Angewandte Chemie 135:30.
Crossref
Crossref
Liton Sikder, Md. Roich Khan, Shanita Zaman Smrity, Muhammad Torequl Islam & Shams Ara Khan. (2022) Phytochemical and pharmacological investigation of the ethanol extract of Byttneria pilosa Roxb.. Clinical Phytoscience 8:1.
Crossref
Crossref
Francisco López-Muñoz, Pilar D’Ocón, Alejandro Romero, José A Guerra & Cecilio Álamo. (2022) Role of serendipity in the discovery of classical antidepressant drugs: Applying operational criteria and patterns of discovery. World Journal of Psychiatry 12:4, pages 588-602.
Crossref
Crossref
Stephen M. Carl, Dea Herrera‐Ruiz, Rajinder K. Bhardwaj, Olafur Gudmundsson, Stephanie Mowery & Gregory T. Knipp. 2022. Drug Transporters. Drug Transporters
115
142
.
Troy J. Scott & Nicholas S. Vonortas. (2019) Microgravity protein crystallization for drug development: a bold example of public sector entrepreneurship. The Journal of Technology Transfer 46:5, pages 1442-1461.
Crossref
Crossref
Bilal Shaker, Myung-Sang Yu, Jingyu Lee, Yongmin Lee, Chanjin Jung & Dokyun Na. (2020) User guide for the discovery of potential drugs via protein structure prediction and ligand docking simulation. Journal of Microbiology 58:3, pages 235-244.
Crossref
Crossref
Larisa Đurić, Maja Milanović, Nataša Milošević & Nataša Milić. (2020) New pharmaceuticals: The importance of serendipity. Medicinski casopis 54:4, pages 143-148.
Crossref
Crossref
J. Polanski. 2020. Comprehensive Chemometrics. Comprehensive Chemometrics
635
676
.
Kosuke Kato, Shin Ito & Kazuhiko Itaya. (2019) Can Accidental Discoveries be Managed? Exploring Key Factors Impacting Idea Generation in R&D Sites in Japan. International Journal of Innovation and Technology Management 16:06.
Crossref
Crossref
Camille Grange, Izak Benbasat & Andrew Burton-Jones. (2019) With a little help from my friends: Cultivating serendipity in online shopping environments. Information & Management 56:2, pages 225-235.
Crossref
Crossref
Sayada Reemsha Kazmi, Ren Jun, Myeong-Sang Yu, Chanjin Jung & Dokyun Na. (2019) In silico approaches and tools for the prediction of drug metabolism and fate: A review. Computers in Biology and Medicine 106, pages 54-64.
Crossref
Crossref
David R. Armstrong, John M. Berrisford, Matthew J. Conroy, Alice R. Clark, Deepti Gupta & Abhik Mukhopadhyay. 2019. Encyclopedia of Bioinformatics and Computational Biology. Encyclopedia of Bioinformatics and Computational Biology
460
471
.
Mark Andrew Phillips, Marisa A. Stewart, Darby L. Woodling & Zhong-Ru Xie. 2018. Molecular Docking. Molecular Docking.
Lothar Terfloth, Simon Spycher & Johann Gasteiger. 2018. Applied Chemoinformatics. Applied Chemoinformatics
165
194
.
Sanjoy S. Ningthoujam, Anupam D. Talukdar, Satyajit D. Sarker, Lutfun Nahar & Manabendra D. Choudhury. 2018. Computational Phytochemistry. Computational Phytochemistry
43
73
.
Kosuke Kato, Shin Ito & Kazuhiko Itaya. (2017) Exploring Effective Factors for the Generation of Innovative Ideas and Technologies in Functional Food R&D. Exploring Effective Factors for the Generation of Innovative Ideas and Technologies in Functional Food R&D.
Joo Chuan Tong. 2017. Drug Design: Principles and Applications. Drug Design: Principles and Applications
1
7
.
Geetha Ramakrishnan. 2017. Translational Bioinformatics and Its Application. Translational Bioinformatics and Its Application
3
28
.
Nawal Alarfaj & Maha El-Tohamy. (2016) New Electrochemically-Modified Carbon Paste Inclusion β-Cyclodextrin and Carbon Nanotubes Sensors for Quantification of Dorzolamide Hydrochloride. International Journal of Molecular Sciences 17:12, pages 2027.
Crossref
Crossref
Adriano M. Luchi, Emilio L. Angelina, Sebastián A. Andujar, Ricardo D. Enriz & Nélida M. Peruchena. (2016) Halogen bonding in biological context: a computational study of D2 dopamine receptor. Journal of Physical Organic Chemistry 29:11, pages 645-655.
Crossref
Crossref
Emrah AKÇAY. (2016) KOLLUĞUN GÖZLEM ve KARAR VERME BECERİLERİ. Güvenlik Bilimleri Dergisi 2:1, pages 57-77.
Crossref
Crossref
Dean G. Brown & Jonas Boström. (2015) Analysis of Past and Present Synthetic Methodologies on Medicinal Chemistry: Where Have All the New Reactions Gone?. Journal of Medicinal Chemistry 59:10, pages 4443-4458.
Crossref
Crossref
Petra Schneider & Gisbert Schneider. (2016) De Novo Design at the Edge of Chaos. Journal of Medicinal Chemistry 59:9, pages 4077-4086.
Crossref
Crossref
Yan A. Ivanenkov, Mark S. Veselov, Nina V. Chufarova, Alexander G. Majouga, Anna A. Kudryavceva & Alexandre V. Ivachtchenko. (2015) Non-dopamine receptor ligands for the treatment of Parkinson’s disease. Insight into the related chemical/property space. Molecular Diversity 20:1, pages 345-365.
Crossref
Crossref
Imran Masood, Maria H. Kiani, Mahmood Ahmad, Muhammed I. Masood & Hadia Sadaquat. (2015) Major Contributions towards Finding a Cure for Cancer through Chemotherapy: A Historical Review. Tumori Journal 102:1, pages 6-17.
Crossref
Crossref
Douglas B. Kell & Elena Lurie-Luke. (2015) The virtue of innovation: innovation through the lenses of biological evolution. Journal of The Royal Society Interface 12:103, pages 20141183.
Crossref
Crossref
Li Ma, Haiyan Gong, Haiyan Zhu, Qing Ji, Pei Su, Peng Liu, Shannan Cao, Jianfeng Yao, Linlin Jiang, Mingzhe Han, Xiaotong Ma, Dongsheng Xiong, Hongbo R. Luo, Fei Wang, Jiaxi Zhou & Yuanfu Xu. (2014) A Novel Small-molecule Tumor Necrosis Factor α Inhibitor Attenuates Inflammation in a Hepatitis Mouse Model. Journal of Biological Chemistry 289:18, pages 12457-12466.
Crossref
Crossref
T. Elizabeth Workman, Marcelo Fiszman, Thomas C. Rindflesch & Diane Nahl. (2014) Framing serendipitous information-seeking behavior for facilitating literature-based discovery: A proposed model. Journal of the Association for Information Science and Technology 65:3, pages 501-512.
Crossref
Crossref
Umer Rashid & Farzana L. Ansari. 2014. Drug Design and Discovery in Alzheimer's Disease. Drug Design and Discovery in Alzheimer's Disease
40
141
.
Serge Mignani, Saïd El Kazzouli, Mosto Bousmina & Jean-Pierre Majoral. (2013) Dendrimer space concept for innovative nanomedicine: A futuristic vision for medicinal chemistry. Progress in Polymer Science 38:7, pages 993-1008.
Crossref
Crossref
Mats Alvesson & Yiannis Gabriel. (2013) Beyond Formulaic Research: In Praise of Greater Diversity in Organizational Research and Publications. Academy of Management Learning & Education 12:2, pages 245-263.
Crossref
Crossref
Gerhard Klebe. 2013. Drug Design. Drug Design
23
36
.
Nicholas Bodor & Peter Buchwald. 2012. Retrometabolic Drug Design and Targeting. Retrometabolic Drug Design and Targeting
39
70
.
Pranita P. Kore, Madhavi M. Mutha, Rishikesh V. Antre, Rajesh J. Oswal & Sandip S. Kshirsagar. (2012) Computer-Aided Drug Design: An Innovative Tool for Modeling. Open Journal of Medicinal Chemistry 02:04, pages 139-148.
Crossref
Crossref
Ahmet Sacan, Sean Ekins & Sandhya Kortagere. 2012. Bioinformatics and Drug Discovery. Bioinformatics and Drug Discovery
87
124
.
John A. Salon, David T. Lodowski & Krzysztof Palczewski. (2011) The Significance of G Protein-Coupled Receptor Crystallography for Drug Discovery. Pharmacological Reviews 63:4, pages 901-937.
Crossref
Crossref
Jonas Boström, Niklas Falk & Christian Tyrchan. (2011) Exploiting personalized information for reagent selection in drug design. Drug Discovery Today 16:5-6, pages 181-187.
Crossref
Crossref
Matthias Adam. 2011. Science in the Context of Application. Science in the Context of Application
67
83
.
Shayne Cox GadPeter Nollert, Michael D. Feese, Bart L. Staker & Hidong Kim. 2010. Pharmaceutical Sciences Encyclopedia. Pharmaceutical Sciences Encyclopedia.
Ann Attfield & Simon Attfield. 2010. Interacting with Information. Interacting with Information.
Arthur M Doweyko & Lidia M Doweyko. (2009) What is next for small-molecule drug discovery?. Future Medicinal Chemistry 1:6, pages 1029-1036.
Crossref
Crossref
Joachim A. Stellmach. (2009) The influences of the structure and activity of biologically active compounds on the assessment of inventive step. World Patent Information 31:3, pages 226-234.
Crossref
Crossref
Pio García. (2008) Discovery by serendipity: a new context for an old riddle. Foundations of Chemistry 11:1, pages 33-42.
Crossref
Crossref
J. Polanski. 2009. Comprehensive Chemometrics. Comprehensive Chemometrics
459
506
.
Gerhard Klebe. 2009. Wirkstoffdesign. Wirkstoffdesign
23
31
.
Victoria E. Cotton, Eva R. Hoffmann, Mohammed F.F. Abdullah & Rhona H. Borts. 2009. Meiosis. Meiosis
3
20
.
Jack Andrew Bikker & Lakshmi S. Narasimhan. 2010. Lead-Seeking Approaches. Lead-Seeking Approaches
85
124
.
Thierry Langer & Sharon D. Bryant. 2008. The Practice of Medicinal Chemistry. The Practice of Medicinal Chemistry
210
227
.
François Chast. 2008. The Practice of Medicinal Chemistry. The Practice of Medicinal Chemistry
1
62
.
Paul J. Lewi & Adam Smith. (2007) Successful pharmaceutical discovery: Paul Janssen's concept of drug research. R&D Management 37:4, pages 355-362.
Crossref
Crossref
Humberto González-Díaz, Isis Bonet, Carmen Terán, Erik De Clercq, Rafael Bello, Maria M. García, Lourdes Santana & Eugenio Uriarte. (2007) ANN-QSAR model for selection of anticancer leads from structurally heterogeneous series of compounds. European Journal of Medicinal Chemistry 42:5, pages 580-585.
Crossref
Crossref
J.K. Ozawa & Q.C. Franco. 2007. Comprehensive Medicinal Chemistry II. Comprehensive Medicinal Chemistry II
725
753
.
Dan C. Fara, Tudor I. Oprea, Eric R. Prossnitz, Cristian G. Bologa, Bruce S. Edwards & Larry A. Sklar. (2006) Integration of virtual and physical screening. Drug Discovery Today: Technologies 3:4, pages 377-385.
Crossref
Crossref
Pascal Muller, Gersande Lena, Eric Boilard, Sofiane Bezzine, Gérard Lambeau, Gilles Guichard & Didier Rognan. (2006)
In
S
ilico
-Guided Target Identification of a Scaffold-Focused Library: 1,3,5-Triazepan-2,6-diones as Novel Phospholipase A2 Inhibitors
. Journal of Medicinal Chemistry 49:23, pages 6768-6778.
Crossref
Crossref
Kubinyi Hugo. 2006. Wiley Handbook of Current and Emerging Drug Therapies. Wiley Handbook of Current and Emerging Drug Therapies.
Andreas Steffen, Andreas Kämper & Thomas Lengauer. (2006) Flexible Docking of Ligands into Synthetic Receptors Using a Two-Sided Incremental Construction Algorithm. Journal of Chemical Information and Modeling 46:4, pages 1695-1703.
Crossref
Crossref
I. Belda, X. Llorà & E. Giralt. (2005) Evolutionary algorithms and de novo peptide design. Soft Computing 10:4, pages 295-304.
Crossref
Crossref
Ignasi Belda, Sergio Madurga, Xavier Llorà, Marc Martinell, Teresa Tarragó, Mireia G. Piqueras, Ernesto Nicolás & Ernest Giralt. (2005) ENPDA: an evolutionary structure-based de novo peptide design algorithm. Journal of Computer-Aided Molecular Design 19:8, pages 585-601.
Crossref
Crossref
S. Alban. (2005) From heparins to factor Xa inhibitors and beyond. European Journal of Clinical Investigation 35:s1, pages 12-20.
Crossref
Crossref
Andrew Hopkins, Jerry Lanfear, Christopher Lipinski & Lee Beeley. 2005. Annual Reports in Medicinal Chemistry Volume 40. Annual Reports in Medicinal Chemistry Volume 40
339
348
.
Jurgen Kopp & Torsten Schwede. (2004) Automated protein structure homology modeling: a progress report. Pharmacogenomics 5:4, pages 405-416.
Crossref
Crossref
Humberto Gonzáles-Díaz, Ornella Gia, Eugenio Uriarte, Ivan Hernádez, Ronal Ramos, Mayrelis Chaviano, Santiago Seijo, Juan A. Castillo, Lázaro Morales, Lourdes Santana, Delali Akpaloo, Enrique Molina, Maikel Cruz, Luis A. Torres & Miguel A. Cabrera. (2003) Markovian chemicals "in silico" design (MARCH-INSIDE), a promising approach for computer-aided molecular design I: discovery of anticancer compounds. Journal of Molecular Modeling 9:6, pages 395-407.
Crossref
Crossref
Lothar Terfloth & Johann Gasteiger. 2003. The Practice of Medicinal Chemistry. The Practice of Medicinal Chemistry
131
145
.
Hugo O. Villar. 2001. Kirk-Othmer Encyclopedia of Chemical Technology. Kirk-Othmer Encyclopedia of Chemical Technology.
Tudor I. Oprea. (2002) Chemical space navigation in lead discovery. Current Opinion in Chemical Biology 6:3, pages 384-389.
Crossref
Crossref
Klaus Mosbach, Yihua Yu, Jens Andersch & Lei Ye. (2001) Generation of New Enzyme Inhibitors Using Imprinted Binding Sites: The Anti-Idiotypic Approach, a Step toward the Next Generation of Molecular Imprinting. Journal of the American Chemical Society 123:49, pages 12420-12421.
Crossref
Crossref
Tudor I. Oprea & Johan Gottfries. (2001) Chemography: The Art of Navigating in Chemical Space. Journal of Combinatorial Chemistry 3:2, pages 157-166.
Crossref
Crossref
Gisbert Schneider. 2000. Virtual Screening for Bioactive Molecules. Virtual Screening for Bioactive Molecules
161
186
.
Martin Stahl. 2000. Virtual Screening for Bioactive Molecules. Virtual Screening for Bioactive Molecules
229
264
.
Christoph A. Sotriffer, Haihong Ni & J. Andrew McCammon. (2000) HIV-1 Integrase Inhibitor Interactions at the Active Site: Prediction of Binding Modes Unaffected by Crystal Packing. Journal of the American Chemical Society 122:25, pages 6136-6137.
Crossref
Crossref
Ernesto Estrada, Eugenio Uriarte, Alina Montero, Marta Teijeira, Lourdes Santana & Erik De Clercq. (2000) A Novel Approach for the Virtual Screening and Rational Design of Anticancer Compounds. Journal of Medicinal Chemistry 43:10, pages 1975-1985.
Crossref
Crossref
H.M. Greenblatt, G. Kryger, T. Lewis, I. Silman & J.L. Sussman. (1999) Structure of acetylcholinesterase complexed with (−)-galanthamine at 2.3 Å resolution. FEBS Letters 463:3, pages 321-326.
Crossref
Crossref
Camille Grange, Izak Benbasat & Andrew Burton-Jones. (2017) With a Little Help from My Friends: Cultivating Serendipity in Online Shopping Environments. SSRN Electronic Journal.
Crossref
Crossref